| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,390 |
3,532 |
$393K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,607 |
2,531 |
$342K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
448 |
448 |
$56K |
| 99215 |
Prolong outpt/office vis |
258 |
256 |
$43K |
| 99401 |
|
1,034 |
1,000 |
$21K |
| 93000 |
|
1,429 |
1,425 |
$18K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
990 |
950 |
$18K |
| H0049 |
Alcohol and/or drug screening |
1,435 |
1,428 |
$16K |
| 99497 |
|
577 |
576 |
$14K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,515 |
1,507 |
$9K |
| 90674 |
|
281 |
281 |
$9K |
| 90651 |
|
12 |
12 |
$3K |
| 99443 |
|
29 |
28 |
$3K |
| 90756 |
|
95 |
95 |
$2K |
| 90661 |
|
62 |
62 |
$2K |
| 90688 |
|
118 |
118 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,051 |
1,049 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,869 |
1,852 |
$2K |
| 0012A |
|
33 |
33 |
$1K |
| 97750 |
|
270 |
269 |
$1K |
| 3074F |
|
632 |
621 |
$1K |
| 3078F |
|
486 |
476 |
$900.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$616.30 |
| 90686 |
|
30 |
30 |
$584.82 |
| 99051 |
|
144 |
135 |
$184.23 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
101 |
101 |
$168.88 |
| 3079F |
|
14 |
12 |
$25.00 |
| 1159F |
|
383 |
383 |
$20.00 |
| 1160F |
|
239 |
239 |
$20.00 |
| 1158F |
|
342 |
341 |
$9.00 |
| 94760 |
|
362 |
360 |
$6.46 |
| 91301 |
|
31 |
31 |
$0.01 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
164 |
164 |
$0.00 |
| 3080F |
|
12 |
12 |
$0.00 |
| 1126F |
|
12 |
12 |
$0.00 |
| 3288F |
|
169 |
169 |
$0.00 |
| 0518F |
|
169 |
169 |
$0.00 |